Titusville, NJ, United States of America

William N Washburn

This inventor holds 39 USPTO granted patents, plus 2 CIPO patents and 6 EPO patents, primarily in Melanin Receptor Antagonists. Top assignees: Bristol-Myers Squibb Compnay, Sterling Winthrop Inc., University of California. Active years: 1993-2017.

USPTO Granted Patents = 39

% Patents Active = 92.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 3.5

ph-index = 14

Forward Citations = 1,165(Granted Patents)

Company Filing History:

30 out of 3,737

Bristol-Myers Squibb Compnay

patents

4 out of 206

Sterling Winthrop Inc.

patents

3 out of 16,008

University of California

where one patent can have more than one assignee

Years Active: 1993-2017

Loading Chart...

Areas of Expertise:

Melanin Concentrating Hormone

SGLT2 Inhibitors

Immunomodulating Agents

TGR5 Receptor Modulators

Pyrrolone Compounds

Thieno[3,2-D]Pyrimidines

Beta 3 Adrenergic Agonists

Hydrolytic Enzyme Inhibitors

Pyrazinone Antagonists

Catecholamine Surrogates

Anilide Ligands

Phenolic Compounds

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9586900 - Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists (2017-03-07),

2. 9499482 - Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists (2016-11-22),

3. 9062028 - Bicyclic nitrogen containing heteroaryl TGR5 receptor modulators (2015-06-23),

4. 8883743 - Methods for treating obesity employing an SGLT2 inhibitor (2014-11-11),

5. 8754211 - Azolotriazinone melanin concentrating hormone receptor-1 antagonists (2014-06-17),

6. 8618115 - Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them (2013-12-31),

7. 8580959 - Azolotriazinone melanin concentrating hormone receptor-1 antagonists (2013-11-12),

8. 8563583 - Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists (2013-10-22),

9. 8415386 - Azolopyrrolone melanin concentrating hormone receptor-1 antagonists (2013-04-09),

10. 8344160 - Pyrrolone melanin concentrating hormone receptor-1 antagonists (2013-01-01),

11. 8088743 - Methods for treating obesity employing an SGLT2 inhibitor (2012-01-03),

12. 8067420 - Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods (2011-11-29),

13. 8012984 - Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods (2011-09-06),

14. 7989433 - Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonists (2011-08-02),

15. 7973159 - Non-basic melanin concentrating hormone receptor-1 antagonists (2011-07-05),

Title: The Innovative Journey of William N. Washburn

Introduction: William N. Washburn, a pioneering inventor hailing from Titusville, New Jersey, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Washburn's latest patents include a revolutionary solar-powered water purification system designed to provide clean drinking water in remote areas, and a cutting-edge drone technology for agricultural purposes.

Career Highlights: With a career spanning over two decades, Washburn has established himself as a leading figure in the field of renewable energy and sustainable technology. His work has been instrumental in addressing pressing global challenges such as water scarcity and food security.

Collaborations: Throughout his career, Washburn has collaborated with top research institutions, universities, and leading tech companies to further develop and commercialize his inventions. His collaborative efforts have led to the successful implementation of innovative solutions in various industries.

Conclusion: William N. Washburn's relentless pursuit of innovation and commitment to creating a positive impact on society have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of inventors and shape the future of technology.